Short description
Nu-Med Plus is a medical device company that develops a patented technology to safely deliver precision doses of nitric oxide.
Description
Nu-Med Plus develops a patented technology to safely deliver precision doses of nitric oxide. A line of innovative systems is being developed to serve new patient populations. Delivered correctly, nitric oxide holds the potential to dilate constricted blood vessels in heart patients and heal respiratory complications in newborns. The company scientists employ patented and patent-pending technology to also explore the potential of nitric oxide to treat wound care and those suffering from malaria, COPD, tuberculosis, and ARDS.
The company was established in 2011 and is based in Salt Lake City, Utah, United States.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Salt Lake City, Utah, United States, North America
Founded on
January 1, 2011
Exited on
September 30, 2014
Went public on
September 30, 2014
Stock symbol
NUMD
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$7890 - 12340
Sign in for full access